DCM
DAFNA Capital Management Portfolio holdings
AUM
$431M
1-Year Est. Return
68.38%
This Fund
S&P 500
1 Year Est. Return
+68.38%
AUM
$405M
AUM Growth
+$42.5M
(+12%)
Holding
83
Top Buys
| 1 | +$3.93M | |
| 2 | +$2.46M | |
| 3 | +$2.02M | |
| 4 |
Inspire Medical Systems
INSP
|
+$1.74M |
| 5 |
Aquestive Therapeutics
AQST
|
+$1.6M |
Top Sells
| 1 | +$21.6M | |
| 2 | +$11.6M | |
| 3 | +$7.37M | |
| 4 |
Mineralys Therapeutics
MLYS
|
+$6.23M |
| 5 |
UroGen Pharma
URGN
|
+$5.78M |
Sector Composition
| 1 | Healthcare | 85.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
76
DELISTED
Blueprint Medicines
BPMC
| – | – |
-168,763
|
|
||
77
Gossamer Bio
GOSS
$98.3M
| – | – |
-849,921
|
|
||
78
InflaRx
IFRX
$62.3M
| – | – |
-200,000
|
|
||
|
ITOS
79
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-140,847
|
|
||
80
Procept Biorobotics
PRCT
$1.27B
| – | – |
-3,000
|
|
||
81
VYNE Therapeutics
VYNE
$20M
| – | – |
-636,103
|
|
||
|
PVLA
82
Palvella Therapeutics
PVLA
$1.6B
| – | – |
-43,348
|
|